Laboratory Corp of America Holdings (LH) Stock Price, Quote & News

Company Profile

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 336-229-1127

Website: www.labcorp.com

Address:

358 South Main Street, Burlington, United States

ZacksResearch Mar. 4 at 1:35 PM

$LH up 10.2% in the past year, but are macro headwinds a threat? ⚠️ 🔍 Strategic test expansion in neurology, oncology, & autoimmune disease 🚀 🌍 Currency fluctuations & geopolitical tensions could dent overseas revenues Discover the full growth vs. risk analysis here 👉 https://www.zacks.com/stock/news/2878452/is-this-the-right-time-to-hold-labcorp-stock-in-your-portfolio?cid=sm-stocktwits-2-2878452-body-35856&ADID=SYND_STOCKTWITS_TWEET_2_2878452_BODY_35856

0 · Reply

ZacksResearch Mar. 4 at 12:35 PM

$LH is pushing for growth — but macro and currency risks aren’t going away ⚠️ The company is eyeing expansion through specialty test growth, acquisitions, and LaunchPad savings initiatives. Solid internal levers… yet currency headwinds and broader macro pressures are still clouding the outlook. Is this a smart long-term setup or a near-term grind? Full breakdown here 👉 https://www.zacks.com/stock/news/2878452/is-this-the-right-time-to-hold-labcorp-stock-in-your-portfolio?cid=sm-stocktwits-2-2878452-teaser-35851&ADID=SYND_STOCKTWITS_TWEET_2_2878452_TEASER_35851

0 · Reply

smartkarma Feb. 25 at 9:02 PM

$LH | LH US - Labcorp's BIGGEST Pressure Point Is 13.5% Early Development Decline "Labcorp Holdings reported strong financial performance for the fourth quarter and full year 2025, with notable advancements across various..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/lh-us-labcorp-s-biggest-pressure-point-is-13-5-early-development-decline

0 · Reply

IN0V8 Feb. 25 at 7:02 PM

$LH 2/24 Piper Sandler raises target price to $300 from $270

0 · Reply

erevnon Feb. 24 at 5:40 PM

Piper Sandler maintains Labcorp Hldgs $LH at Neutral and raises the price target from $270 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

EarningsCentral Feb. 20 at 3:45 AM

$LH Q4 2025 Earnings | Record Cash Flow, FDA Cleared Alzheimer’s Test & Future https://youtu.be/NgDtYaGO8nw

0 · Reply

Nosh Feb. 20 at 2:45 AM

$LH Nice recovery...does it hold.

0 · Reply

erevnon Feb. 18 at 2:31 PM

Baird maintains Labcorp Hldgs $LH at Outperform and raises the price target from $313 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

ZacksResearch Feb. 17 at 7:10 PM

$LH beats on earnings… and the stock still drops? 👀 Q4 EPS jumped 18% and topped estimates, but a revenue miss is stealing the spotlight — and shares are sliding in pre-market as investors react cautiously. Is this a buy-the-dip setup or a warning sign? Get the full breakdown 👉 https://www.zacks.com/stock/news/2870557/labcorp-q4-earnings-beat-revenues-miss-stock-down-in-pre-market?cid=sm-stocktwits-2-2870557-teaser-33906&ADID=SYND_STOCKTWITS_TWEET_2_2870557_TEASER_33906

0 · Reply

AStrokeOfLuck Feb. 17 at 4:28 PM

$LH

0 · Reply

Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide

Feb 17, 2026, 4:15 PM EST - 26 days ago

Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript

Feb 17, 2026, 7:59 AM EST - 27 days ago

Labcorp forecasts upbeat annual profit on strong demand for diagnostic products

Feb 17, 2026, 6:50 AM EST - 27 days ago

Labcorp Announces 2025 Fourth Quarter and Full Year Results

Feb 11, 2026, 7:00 AM EST - 4 weeks ago

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care

Feb 9, 2026, 8:30 AM EST - 5 weeks ago

Labcorp Appoints John H. Sampson, M.D.

Jan 15, 2026, 4:15 PM EST - 2 months ago

Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026

Jan 14, 2026, 6:50 AM EST - 2 months ago

Labcorp Declares Quarterly Dividend

Jan 13, 2026, 10:15 PM EST - 2 months ago

Labcorp Holdings Inc. (LH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 7:00 AM EST - 2 months ago

Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk

Jan 8, 2026, 9:00 AM EST - 2 months ago

Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs

Jan 8, 2026, 8:30 AM EST - 2 months ago

NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp

Dec 30, 2025, 4:15 PM EST - 2 months ago

Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 10:00 AM EST - 3 months ago

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks

Dec 2, 2025, 4:15 PM EST - 3 months ago

Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp

CYH

Nov 24, 2025, 8:30 AM EST - 4 months ago

Labcorp Appoints Victor Bulto to Board of Directors

Nov 19, 2025, 7:04 AM EST - 4 months ago

Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research

Nov 17, 2025, 9:00 AM EST - 4 months ago

Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research

Oct 28, 2025, 2:45 PM EDT - 4 months ago

Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support

Oct 28, 2025, 12:31 PM EDT - 4 months ago

Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 6:52 AM EDT - 4 months ago

Labcorp lifts annual profit forecast on strong diagnostic test demand

Oct 28, 2025, 6:50 AM EDT - 4 months ago

Labcorp Announces 2025 Third Quarter Results

Oct 23, 2025, 7:00 AM EDT - 5 months ago

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Oct 20, 2025, 9:00 AM EDT - 5 months ago

Praia Health, Providence, and Labcorp Collaborate to Transform Patient Engagement and Lab Order Adherence

Sep 30, 2025, 7:00 AM EDT - 5 months ago

Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities

Sep 25, 2025, 4:15 PM EDT - 6 months ago

Labcorp to Announce Third Quarter Financial Results on October 28, 2025

Sep 15, 2025, 8:30 AM EDT - 6 months ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

OPK

Sep 9, 2025, 10:26 AM EDT - 6 months ago

Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 27, 2025, 4:15 PM EDT - 7 months ago

Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 18, 2025, 7:00 AM EDT - 7 months ago

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

Jul 30, 2025, 7:12 AM EDT - 8 months ago

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

Jul 29, 2025, 7:00 AM EDT - 8 months ago

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

Jul 25, 2025, 9:45 AM EDT - 8 months ago

These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings

Jul 24, 2025, 2:38 PM EDT - 8 months ago

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 12:27 PM EDT - 8 months ago

Why Is Testing Giant Labcorp Stock Surging On Thursday?

Jul 24, 2025, 7:00 AM EDT - 8 months ago

Labcorp raises annual profit forecast on strong diagnostic testing demand

Jul 24, 2025, 6:50 AM EDT - 8 months ago

Labcorp Announces 2025 Second Quarter Results

Jul 22, 2025, 4:15 PM EDT - 8 months ago

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

CYH

Jun 30, 2025, 6:58 AM EDT - 9 months ago

Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low

Jun 26, 2025, 4:10 PM EDT - 9 months ago

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

Jun 2, 2025, 7:00 AM EDT - 10 months ago

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage

May 30, 2025, 7:00 AM EDT - 10 months ago

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

May 8, 2025, 4:15 PM EDT - 11 months ago

Labcorp to Webcast Its Annual Meeting of Shareholders May 15

Apr 29, 2025, 4:21 PM EDT - 11 months ago

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 6:56 AM EDT - 11 months ago

Labcorp beats quarterly profit estimate on diagnostic test demand

Apr 29, 2025, 6:50 AM EDT - 11 months ago

Labcorp Announces 2025 First Quarter Results

Apr 23, 2025, 7:00 AM EDT - 11 months ago

Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions

Apr 11, 2025, 5:32 AM EDT - 1 year ago

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics

Apr 2, 2025, 7:00 AM EDT - 1 year ago

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease

Apr 1, 2025, 8:32 AM EDT - 1 year ago

Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide

ZacksResearch Mar. 4 at 1:35 PM

0 · Reply

ZacksResearch Mar. 4 at 12:35 PM

0 · Reply

smartkarma Feb. 25 at 9:02 PM

0 · Reply

IN0V8 Feb. 25 at 7:02 PM

$LH 2/24 Piper Sandler raises target price to $300 from $270

0 · Reply

erevnon Feb. 24 at 5:40 PM

Piper Sandler maintains Labcorp Hldgs $LH at Neutral and raises the price target from $270 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

EarningsCentral Feb. 20 at 3:45 AM

$LH Q4 2025 Earnings | Record Cash Flow, FDA Cleared Alzheimer’s Test & Future https://youtu.be/NgDtYaGO8nw

0 · Reply

Nosh Feb. 20 at 2:45 AM

$LH Nice recovery...does it hold.

0 · Reply

erevnon Feb. 18 at 2:31 PM

Baird maintains Labcorp Hldgs $LH at Outperform and raises the price target from $313 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

ZacksResearch Feb. 17 at 7:10 PM

0 · Reply

AStrokeOfLuck Feb. 17 at 4:28 PM

$LH

0 · Reply

1986iamwallstreet Feb. 17 at 2:35 PM

$LH sell the bid in full Play 🩸🩸🩸🩸🩸🩸

0 · Reply

1986iamwallstreet Feb. 17 at 2:16 PM

$LH Revenue Growth Slowing FY 2025 Revenue Growth: 7.2% 2026 Enterprise Guidance: 4.7% – 6.0% Midpoint growth decelerates to ~5.4%. 🩸🩸🩸🩸🩸🩸

0 · Reply

1986iamwallstreet Feb. 17 at 2:16 PM

$LH High Debt Load Total Debt: $5.58B Cash: $532M Net Debt ≈ $5.05B In a rising-rate or tighter credit environment, that leverage matters. Interest expense already $224M annually. 🩸🩸🩸🩸🩸🩸🩸🩸🩸

0 · Reply

1986iamwallstreet Feb. 17 at 2:15 PM

$LH Diagnostics Volume vs Price Mix Requisition volume growth: Organic volume only 1.1% Price/mix 3.0% Volume growth is modest. Pricing is doing more of the work. If reimbursement tightens, that pricing leverage could reverse. 🩸🩸🩸🩸🩸🩸🩸🩸🩸

0 · Reply

1986iamwallstreet Feb. 17 at 2:07 PM

$LH Risk Factors Mentioned (Noteworthy) Management flagged: Payer regulation risk Reimbursement cuts Inflation IT/cyber risk Litigation exposure Tech disruption Employee retention Spin-off tax risk (Fortrea) Healthcare reimbursement risk remains the biggest macro threat.🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸

0 · Reply

OpenOutcrier Feb. 17 at 1:55 PM

$LH (+0.8% pre) Labcorp forecasts upbeat annual profit on strong demand for diagnostic products https://ooc.bz/l/93525

0 · Reply

DonCorleone77 Feb. 17 at 12:27 PM

$LH Labcorp reports Q4 adjusted EPS $4.07, consensus $3.94 Reports Q4 revenue $3.52B, consensus $3.56B. "In 2025, Labcorp grew revenue over 7% and delivered double-digit adjusted EPS growth, margin expansion and strong free cash flow. Performance was driven by continued strength in our Diagnostics and Central Laboratory businesses," said Adam Schechter, Chairman and CEO of Labcorp. "We made significant progress across our strategic priorities, and we begin 2026 with strong momentum, and expect continued strong performance in 2026 as we remain focused on growth."

0 · Reply

1986iamwallstreet Feb. 17 at 12:05 PM

$LH rev miss 🩸🩸🩸🩸

0 · Reply

dontfeedthebashers Feb. 17 at 12:04 PM

$LH okay, but where's my raise 😭

0 · Reply

StocktwitsEarnings Feb. 17 at 12:02 PM

$LH Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $2.00 up 16.28% YoY • Reported revenue of $3.52B up 5.60% YoY • Labcorp expects Full-Year 2026 Enterprise Revenue of $14.61B to $14.79B, a midpoint growth of 5.4%. Adjusted EPS is guided to $17.55 to $18.25, with Free Cash Flow of $1.24B to $1.36B.

0 · Reply

DonCorleone77 Feb. 14 at 3:06 PM

$LH $LDOS $MDT Some notable companies reporting before Tuesday's open, with earnings consensus estimates: - LabCorp (LH), consensus $3.94 - Leidos (LDOS), consensus $2.61 - Medtronic (MDT), consensus $1.33

0 · Reply

tikiyan Feb. 13 at 6:01 PM

$LH when $330?

0 · Reply

Market Cap	21.74B
Revenue (ttm)	13.95B
Net Income (ttm)	876.50M
EPS (ttm)	N/A
PE Ratio	16.05
Forward PE	14.91
Profit Margin	6.28%
Debt to Equity Ratio	0.59

Volume	189,881
Avg Vol	722,912
Day's Range	N/A - N/A
Shares Out	82.40M
Stochastic %K	6%
Beta	1.01
Analysts	Strong Sell
Price Target	$308.70